SOPHiA GENETICS (SOPH) Net Equity Issued and Repurchased (2020)

SOPHiA GENETICS (SOPH) posted Net Equity Issued and Repurchased of $43.0 million for Q3 2020.

SOPHiA GENETICS (SOPH) Net Equity Issued and Repurchased (2020) Analysis & Trends

SOPHiA GENETICS has reported Net Equity Issued and Repurchased for 1 years, with the latest figure at $43.0 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 SOPHiA GENETICS 553.79 Mn 446.12 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2020 42.98 Mn
Sep 30, 2020 42.98 Mn